论文部分内容阅读
上海市中心血站试制的抗过敏球蛋白针剂,每支2ml内含1-1.5％丙种球蛋白和赛庚啶1mg,是治疗过敏性疾病的制剂。我们应用抗过敏球蛋白治疗45例支气管哮喘(下简称哮喘)患者,在治疗过程中测定了嗜酸性细胞、嗜硷性细胞、24小时尿5-羟吲哚 乙酸和类风湿因子;并进行动物抗组织胺和保护作用试验,初步总结如下: 病例选择 45例患者,男25例,女20例。年龄13-58岁,多数在20-40岁。病程2-30年,多为10-15年。其中过敏性哮喘30例,感染性哮喘6例,混合性哮喘9例。哮喘发作程度
Shanghai Center Blood Station trial anti-allergic globulin injection, each containing 2ml 1-1.5% gamma globulin and cyproheptadine 1mg, is the preparation of the treatment of allergic diseases. We treated 45 patients with bronchial asthma (asthma) with anti-allergic globulin and measured eosinophils, basophils, 24-hour urinary 5-hydroxyindoleic acid and rheumatoid factor during the course of treatment; and animals Antihistamine and protective effects of the trial, the initial summary is as follows: 45 cases of patients selected, 25 males and 20 females. Aged 13-58 years old, mostly in the 20-40 years old. Duration of 2 - 30 years, mostly 10-15 years. Including allergic asthma in 30 cases, 6 cases of infectious asthma, mixed asthma in 9 cases. Degree of asthma attack